Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:3-Methyleneoxindole)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004153 AN006894 Multi-omics Study of Small Intestine Adaptation After Total Colectomy in a Rat model Feces Rat Shanghai Jiao Tong University LC-MS
ST004148 AN006877 Surface Acoustic Wave Hemolysis Assay for Evaluating Stored Red Blood Cells Blood Human Blood Disorder University of Colorado School of Medicine LC-MS
ST003944 AN006484 The time-dependence of ranolazine effects on metabolism in A375 and A375-VR cells Cultured cells Human Cancer University of Colorado Denver LC-MS
ST003937 AN006466 Post-transfusion recovery, quality and metabolism of short and long-term stored platelets during controlled inflammation Blood Human University of Colorado Anschutz Medical Campus LC-MS
ST003794 AN006236 Metabolomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Maple syrup urinary disease University of Colorado Denver LC-MS
ST003794 AN006236 Metabolomics characterization of blood samples from patients with maple syrup urine disease (MSUD) in comparison to healthy controls Blood Human Metabolic disease University of Colorado Denver LC-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Human Cancer Universitätsspital Zürich MALDI-MS
ST003655 AN006005 Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor Blood Mouse Cancer Universitätsspital Zürich MALDI-MS
ST003565 AN005857 Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST003489 AN005728 Tryptophan pathway profiling of culture media from TNBC cell line MDA-MB-231 +/- inhibitors of the TDO/IDO pathway. Culture media Human Cancer University of Colorado Anschutz Medical Campus LC-MS
ST003488 AN005726 Tryptophan metabolite profiling of cell supernatants (culture media) from TNBC cell line BT549 grown in suspension with TDO2 knockdown and IDO1 compensation. Culture media Human Cancer University of Colorado Anschutz Medical Campus LC-MS
ST003487 AN005725 Tryptophan metabolite profiling of TNBC cell line BT549 grown in suspension with TDO inhibition. Tumor cells Human Cancer University of Colorado Anschutz Medical Campus LC-MS
ST003486 AN005724 Tryptophan metabolite profiling of cell supernatants (culture media) from TNBC cell line BT549 grown in suspension with TDO inhibition. Culture media Human Cancer University of Colorado Anschutz Medical Campus LC-MS
ST003485 AN005723 Tryptophan metabolite profiling of cell supernatants (culture media) from TNBC cell lines with either overexpression or stable knockdown of TDO2. Culture media Human Cancer University of Colorado Anschutz Medical Campus LC-MS
ST003331 AN005457 Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis - cellular metabolomics Stem cells Human Multiple sclerosis University of Colorado Denver LC-MS
ST003327 AN005451 Control Of Major Bleeding After Trauma (COMBAT) Clinical Research Trial Metabolomics Blood Human Trauma University of Colorado Anschutz Medical Campus LC-MS
ST003315 AN005429 Randomized phase II trial of pre-operative fulvestrant with or without enzalutamide for ER+/Her2- primary breast cancer: effects on tumor immune microenvironment and clinical outcomes. Blood Human Cancer University of Colorado Anschutz Medical Campus LC-MS
ST003179 AN005221 Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003166 AN005195 Metabolomics of Murine WT or MCJ KO CD19-BBz CD8 CAR-T cells T-cells Mouse Cancer University of Colorado School of Medicine LC-MS
ST003160 AN005184 New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST003144 AN005160 On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002926 AN004799 Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002792 AN004543 Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria Blood Plasmodium falciparum Malaria Monash University LC-MS
ST002712 AN004396 Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - metabolomics Cultured cells Human Cancer University of Colorado Denver LC-MS
ST002701 AN004378 Mouse serum metabolomics Blood Mouse Chronic stress China Pharmaceutical University LC-MS
ST002307 AN003769 Metabolomics profiling of the secondary fractions 4 of bacterial culture supernatants. Bacterial cells Bacillus megaterium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002307 AN003769 Metabolomics profiling of the secondary fractions 4 of bacterial culture supernatants. Bacterial cells Enterococcus faecium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Bacillus megaterium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002306 AN003768 Metabolomics profiling of full extracts of bacterial culture supernatants. Bacterial cells Enterococcus faecium Myalgic encephalomyelitis/chronic fatigue syndrome University of Connecticut LC-MS
ST002213 AN003618 Metabolic changes in Alzheimer patient-derived induced neurons versus non-demented controls Fibroblast cells Human Alzheimers disease University of Colorado Denver LC-MS
ST002213 AN003621 Metabolic changes in Alzheimer patient-derived induced neurons versus non-demented controls Fibroblast cells Human Alzheimers disease University of Colorado Denver LC-MS
ST002200 AN003601 Human Trisome Project Plasma Metabolomics v1 Blood Human Down syndrome University of Colorado Denver LC-MS
ST002108 AN003448 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University LC-MS
ST001864 AN003022 Targeting host glycolysis as a strategy for antimalarial development Blood Human Malaria University of Colorado Anschutz Medical Campus LC-MS
ST001788 AN002900 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University LC-MS
ST001736 AN002826 The COVIDome Explorer Researcher Portal (blood plasma) Blood Human COVID-19 University of Colorado Anschutz Medical Campus LC-MS
ST001735 AN002824 The COVIDome Explorer Researcher Portal (Red Blood Cells) Blood Human COVID-19 University of Colorado Anschutz Medical Campus LC-MS
ST001732 AN002819 Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance (part-III) Cultured cells Human Cancer University of Colorado Anschutz Medical Campus LC-MS
ST001731 AN002817 Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance (part-II) Cultured cells Human Cancer University of Colorado Denver LC-MS
ST001549 AN002581 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University LC-MS
ST001547 AN002576 β-Adrenergic regulation of metabolism in macrophages Macrophages Human Monash University LC-MS
ST001243 AN002065 Global Metabolic Analysis Trisomy 21 - Cohort 1 Blood Human Down syndrome University of Colorado Denver LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001204 AN002004 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001202 AN002000 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001201 AN001998 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001175 AN001950 Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum Plasmodium cells Plasmodium falciparum Malaria Monash University LC-MS
ST001033 AN001694 Determination of mode of action of anti-malalrial drugs using untargeted metabolomics Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST000546 AN000832 Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium Cells Plasmodium falciparum Malaria Monash University LC-MS
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000510 AN000782 Assessing metabolic changes to maternal rat liver tissue during and post-pregnancy (part II) Liver Mouse University of Colorado Denver LC-MS
ST000509 AN000780 Metabolic changes to maternal rat liver tissue during and post-pregnancy Liver Rat University of Colorado Denver LC-MS
ST000414 AN000656 Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action Cells Plasmodium falciparum Malaria Monash Institute of Pharmaceutical Sciences LC-MS
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
ST000311 AN000494 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida LC-MS
ST000311 AN000495 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida LC-MS
ST000311 AN000496 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida LC-MS
ST000311 AN000497 TC and B6 untreated plasma in lupus-prone mice Blood Mouse Lupus University of Florida LC-MS
ST000294 AN000471 Mechanisms of Metabolic Cycles in Diapausing Flesh Fly by Metabolomics Approach Whole insect Flesh Fly University of Florida LC-MS
ST000292 AN000466 LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice Blood Human University of Florida LC-MS
ST000291 AN000464 LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice Urine Human University of Florida LC-MS
ST000286 AN000454 Mouse skeletal myotube chronic low-frequency stimulation Myotubes Mouse University of Florida LC-MS
ST000286 AN000455 Mouse skeletal myotube chronic low-frequency stimulation Myotubes Mouse University of Florida LC-MS
  logo